spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chevalier, S.
Right arrow Articles by Roberts, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chevalier, S.
Right arrow Articles by Roberts, R. A.
Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J. and Diehl, A. M (1992). Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol 263, 579-585.

Albrecht, J. H., Poon, R. Y. C., Ahonen, C. L., Rieland, B. M., Deng, C. and Crary, G. S (1998). Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating rat liver. Oncogene 16, 2141-2150.[Medline]

Baroni, G. S., Marucci, L., Benedetti, A., Mancini, R., Jezequel, A. M. and Orlandi, F (1994). Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. J. Hepatol 20, 508-513.[Medline]

Bartles, J. R., Khoun, S., Lin, X., Zhang, L., Reddy, J. K., Rao, M. S., Isoye, S. T., Nehme, C. L. and Fayos, B. E (1990). Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins. Cancer Res 50, 669-676.[Abstract/Free Full Text]

Beyer, H. S. and Theologides, A (1993). Tumor necrosis factor-alpha is a direct hepatocyte mitogen in the rat. Biochem. Mol. Biol. Int 29, 1-4.[Medline]

Bojes, H. K. and Thurman, R. G (1996). Peroxisome proliferators activate kupffer cells in vivo. Cancer Res 56, 1-4.[Abstract/Free Full Text]

Bojes, H. K., Germolec, D. R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M. I. and Thurman, R. G (1997). Antibodies to tumor necrosis factor-alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator WY-14,643. Carcinogenesis 18, 669-674.[Abstract/Free Full Text]

Boyle, C. C. and Hickman, J. A (1997). Toxin-induced increase in survival factor receptors: modulation of the threshold for apoptosis. Cancer Res 57, 2404-2409.[Abstract/Free Full Text]

Bruccoleri, A., Gallucci, R., Germolec, D. R., Blackspear, P., Simeonova, P., Thurman, R. G. and Luster, M. I (1997). Induction of early-immediate genes by tumor necrosis factor-alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25, 133-141.[Medline]

Cattley, R. C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B. et al (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?. Regul. Toxicol. Pharmacol 27, 47-60.

Chevalier, S. and Roberts, R. A (1999). G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent nongenotoxic hepatocarcinogen nafenopin. Carcinogenesis 20, 1209-1213.[Abstract/Free Full Text]

Decker, K (1990). Biologically active products of stimulated liver macrophages (Kuppfer cells). Eur. J. Biochem 192, 245-261.[Medline]

Garcia-Allan, C., Loughlin, J., Orton, T. and Lord, P (1997). Changes in protein and mRNA levels of growth factor/growth factor receptors in rat livers after administration of phenobarbitone or methylclofenapate. Arch. Toxicol 71, 409-415.[Medline]

Gill, J. H., Brickell, P., Dive, C. and Roberts, R. A (1998). The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor. Carcinogenesis 19, 1743-1747.[Abstract/Free Full Text]

Gonzalez, F. J (1997). Recent update on the PPAR alpha-null mouse. Biochimie 79, 139-144.[Medline]

Gupta, C., Hattori, H. and Shinozuka, H (1988). Suppression of EGF binding in rat liver by the hypolidaemic peroxisome proliferators, chloro-6(2,3-xylidino)-2-pyrimidinylthio-(N-beta-hydroxyethyl)acetamide (BR931) and di(2-ethylhexyl) phthalate. Carcinogenesis 9, 167-169.[Abstract/Free Full Text]

Issemann, I. and Green, S (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.[Medline]

James, N. H. and Roberts, R. A (1994). The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. Carcinogenesis 15, 2687-2694.[Abstract/Free Full Text]

James, N. H. and Roberts, R. A (1996). Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than with suppression of apoptosis. Carcinogenesis 17, 1623-1632.[Abstract/Free Full Text]

Jones, H. E., Dutkowski, C. M., Barrow, D., Harper, M. E., Wakeling, A. E. and Nicholson, R. I (1997). New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145. Int. J. Cancer 71, 1010-1018.[Medline]

Kato, A., Ota, S., Bamba, H., Wong, R. M., Ohmura, E., Imai, Y. and Matsuzaki, F (1998). Regulation of cyclin D dependent kinase activity in rat liver regeneration. Biochem. Biophys. Res. Commun 245, 70-74.[Medline]

Kost, D. P. and Michalopoulos, G. K (1991). Effect of 2% DMSO on the mitogenic properties of epidermal growth factor and hepatocyte growth factor in primary hepatocyte culture. J. Cell. Physiol 147, 274-280.[Medline]

Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H. and Gonzalez, F. J (1995). Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleitrophic effects of peroxisome proliferators. Mol. Cell. Biol 15, 3012-3022.[Abstract]

Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L. and Guguen-Guillouzo, C (1994). Expression and activation of CDKs (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J. Biol. Chem 269, 2491-2500.[Abstract/Free Full Text]

Loyer, P., Cariou, S., Glaise, D., Bilodeau, M., Baffet, G. and Guguen-Guillouzo, C (1996). Growth factor dependence of progression through G1and S phases of adult rat hepatocytes in vitro. J. Biol. Chem 271, 11484-11492.[Abstract/Free Full Text]

Michalopoulos, G. K (1990). Liver regeneration: molecular mechanisms of growth control. FASEBJ 4, 176-187.[Abstract]

Michalopoulos, G. K. and DeFrances, M. C (1997). Liver regeneration. Science 276, 60-66.[Abstract/Free Full Text]

Moody, D. E., Reddy, J. K., Lake, B. G., Popp, J. A. and Reese, D. H (1991). Peroxisome proliferation and non-genotoxic carcinogenesis: commentary on a symposium. Fund. Appl. Toxicol 6, 233-248.

Peters, J. M., Cattley, R. C. and Gonzalez, F. J (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator, Wy-14,643. Carcinogenesis 18, 2029-2033.[Abstract/Free Full Text]

Peters, J. M., Aoyama, T., Cattley, R. C., Nobumitsu, U., Hashimoto, T. and Gonzalez, F. J (1998). Role of peroxisome proliferator-activated receptor a in altered cell cyle regulation in mouse liver. Carcinogenesis 19, 1989-1994.[Abstract/Free Full Text]

Rininger, J. A., Goldsworthy, T. L. and Babish, J. G (1997). Time-course comparison of cell cycle protein expression following partial hepatectomy and Wy-14,643-induced hepatic proliferation in F344 rats. Carcinogenesis 18, 935-941.[Abstract/Free Full Text]

Rolfe, M., James, N. H. and Roberts, R. A (1997). Tumour necrosis factor alpha (TNF-alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators?. Carcinogenesis 18, 2277-2280.[Abstract/Free Full Text]

Rose, M. L., Germolec, D., Schoonhoven, R. and Thurman, R. G (1997). Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18, 1453-1456.[Abstract/Free Full Text]

Rusyn, I., Tsukamoto, H. and Thurman, R. G (1998). Wy-14,643 rapidly activates nuclear factor kB in Kupffer cells before hepatocyte. Carcinogenesis 19, 1217-1222.[Abstract/Free Full Text]

Sherr, C. J. and Roberts, J. M (1995). Inhibitors of mammalian G1cyclin-dependent kinases. Genes Dev 9, 1149-1163.[Free Full Text]

Steineger, H. H., Sorensen, H. N., Tugwood, J. D., Skrede, S., Spydevold, O. and Gautvik, K. M (1994). Dexamethasone and insulin demonstrate marked and opposite regulation of steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Eur. J. Biochem 225, 967-974.[Medline]

Wakeling, A. E., Barker, A. J., Davies, D. H., Brown, D. S., Green, L. R., Cartlidge, S. A. and Woodburn, J. R (1996). Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines. Breast Cancer Res. Treat 1996, 67-73.

Webber, E. M., Bruix, J., Pierce, R. H. and Fausto, N (1998). Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28, 1226-1234.[Medline]

Yamada, Y., Kirillova, I., Peschon, J. J. and Fausto, N (1997). Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci.USA 94, 141-1446.

Yarden, Y. and Ullrich, A (1998). Growth factor receptor tyrosine kinases. Ann. Rev. Biochem 57, 443-478.[Medline]


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
W. Parzefall, W. Berger, E. Kainzbauer, O. Teufelhofer, R. Schulte-Hermann, and R. G. Thurman
Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes
Carcinogenesis, March 1, 2001; 22(3): 519 - 523.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. C. Hasmall, D. A. West, K. Olsen, and R. A. Roberts
Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro
Carcinogenesis, December 1, 2000; 21(12): 2159 - 2165.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Cosulich, N. James, and R. Roberts
Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators
Carcinogenesis, April 1, 2000; 21(4): 579 - 584.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chevalier, S.
Right arrow Articles by Roberts, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chevalier, S.
Right arrow Articles by Roberts, R. A.